Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.6
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Net sales $ 215,991 $ 265,514 $ 439,623 $ 555,370
Operating costs and expenses:        
Cost of sales 183,053 203,319 374,374 413,823
Selling, general and administrative expenses 27,983 28,355 55,238 58,631
Research and development 6,833 7,362 14,566 14,448
Restructuring charges 8,522 1,605 9,786 2,630
Goodwill impairment 1,092   1,092  
Write down of long-lived assets 4,234   4,234  
Settlement gain on benefit plan (1,675)   (1,675)  
Net (gain) loss on sales and disposals of assets (31) (40) 73 83
Total operating costs and expenses 230,011 240,601 457,688 489,615
Operating income (loss) (14,020) 24,913 (18,065) 65,755
Other (income) expense:        
Interest income (26) (31) (57) (74)
Interest expense 10,136 7,282 20,593 14,682
Other (income) expense, net (996) 1,297 515 1,202
Income (loss) before income taxes (23,134) 16,365 (39,116) 49,945
Income tax expense 1,787 2,047 3,558 3,778
Net income (loss) $ (24,921) $ 14,318 $ (42,674) $ 46,167
Net income (loss) per share:        
Basic (in dollars per share) $ (0.55) $ 0.32 $ (0.95) $ 1.10
Diluted (in dollars per share) $ (0.55) $ 0.27 $ (0.95) $ 0.88
Weighted-average shares outstanding:        
Basic (in shares) 44,911 44,370 44,860 41,924
Diluted (in shares) 44,911 52,230 44,860 52,307